Evidence map›Paper›PMID 42839016›Full record

ArticleExperimental & molecular medicine2026

MSL2 orchestrates oligodendrocyte precursor cell cycle via H3K4me3 to prevent white matter defects in neurodevelopmental disorders.

Jie Yuan, Yuhao Dong, Kaixiang Zhang, Zhongcheng Wei, Zhongzhe Zhang, Ming Zhang, Shengjie Luo, Sufang Jiang, Yu Peng, Xinghan Wu and 7 more

Abstract read
PubMed Publisher
In one paragraph

Article in Experimental & molecular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Jie YuanDepartment of Neurobiology, School of Basic Medicine, Fourth Military Medical University, Xi'an, Shaanxi, China.
Yuhao DongDepartment of Neurobiology, School of Basic Medicine, Fourth Military Medical University, Xi'an, Shaanxi, China.
Kaixiang ZhangDepartment of Neurobiology, School of Basic Medicine, Fourth Military Medical University, Xi'an, Shaanxi, China.
Zhongcheng WeiDepartment of Neurobiology, School of Basic Medicine, Fourth Military Medical University, Xi'an, Shaanxi, China.
Zhongzhe ZhangDepartment of Neurobiology, School of Basic Medicine, Fourth Military Medical University, Xi'an, Shaanxi, China.
Ming ZhangDepartment of Neurobiology, School of Basic Medicine, Fourth Military Medical University, Xi'an, Shaanxi, China.
Shengjie LuoCenter for Medical Genetics, Hunan Key Laboratory of Medical Genetics, MOE Key Lab of Rare Pediatric Diseases, School of Life Sciences, Central South University, Changsha, Hunan, China.
Sufang JiangDepartment of Neurobiology, School of Basic Medicine, Fourth Military Medical University, Xi'an, Shaanxi, China.
Yu PengDepartment of Medical Genetics, The Affiliated Children's Hospital of Xiangya School of Medicine (Hunan Children's Hospital), Central South University, Changsha, Hunan, China.
Xinghan WuDepartment of Medical Genetics, The Affiliated Children's Hospital of Xiangya School of Medicine (Hunan Children's Hospital), Central South University, Changsha, Hunan, China.
Herenger YvanGenetica AG, Human Genetics and Genetic Counselling Unit, Zurich, Switzerland.
Himanshu GoelHunter Genetics, Waratah, NSW, Australia.
Elaine ZhangMurdoch Children's Research Institute, Royal Children's Hospital, Melbourne, VIC, Australia.
Australian Undiagnosed Diseases Network (UDN-Aus)
Hui GuoCenter for Medical Genetics, Hunan Key Laboratory of Medical Genetics, MOE Key Lab of Rare Pediatric Diseases, School of Life Sciences, Central South University, Changsha, Hunan, China. guohui2@csu.edu.cn.ORCID http://orcid.org/0000-0002-1570-2545
Shengxi WuDepartment of Neurobiology, School of Basic Medicine, Fourth Military Medical University, Xi'an, Shaanxi, China. shengxi@fmmu.edu.cn.ORCID https://orcid.org/0000-0002-3210-9567
Xianghui ZhaoDepartment of Neurobiology, School of Basic Medicine, Fourth Military Medical University, Xi'an, Shaanxi, China. xianghuizhao@fmmu.edu.cn.ORCID http://orcid.org/0000-0003-1165-0140

Funding

National Natural Science Foundation of China (National Science Foundation of China) 32371021
6 · The paper itself

Abstract

Pathogenic variants in MSL2, a core component of the histone-modifying MSL complex, are associated with neurodevelopmental disorders (NDDs) and white matter abnormalities; however, their mechanisms of pathogenicity remain unknown. In this study, we identified three patients with NDD carrying MSL2 variants, all of whom exhibited white matter abnormalities. Using conditional knockout mice, we demonstrated that oligodendrocyte lineage-specific deletion of Msl2 disrupts oligodendrocyte precursor cell proliferation, maturation, and myelination in a cell-autonomous manner, leading to autism-like behaviors including social deficits and repetitive behaviors. Integrated transcriptomic and epigenomic profiling revealed that MSL2 maintains H3K4me3 occupancy at promoters of genes essential for cell cycle progression, mitotic spindle assembly, and myelination, whereas its loss aberrantly activates immune-related pathways. Furthermore, a cell synchronization study confirmed that MSL2 is required for metaphase spindle formation in oligodendrocyte precursor cells, providing a mechanistic basis for impaired oligodendroglial development and hypomyelination. Our findings establish MSL2 as a critical epigenetic regulator of oligodendrocyte lineage progression and propose MSL2-targeted interventions as a promising therapeutic strategy for NDD-related white matter defects.

Identifiers

PMID42839016

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.